Total Knee Arthroplasty: Functional and Clinical Outcomes

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT01811563
Collaborator
(none)
60
1
2
36.8
1.6

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the differences in functional and patient reported outcomes between total knee replacement (TKA) implants. In addition, this work will examine the correlation between functional assessments and patient reported outcomes following surgery. All subjects will complete assessments preoperatively, 4-6 weeks following TKA and then one year following TKA. Subjects will complete a series of patient reported outcomes as well as a series of functional outcomes at each of the time points of interest. The analysis will include a repeated measures design to determine differences between groups across time as well as correlations between the functional and patient reported outcomes. This work will hopefully determine the importance of using objective functional outcomes following TKA as well as determining the need for patient assessments out to one year following surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Zimmer
  • Device: Stryker
N/A

Detailed Description

The number differences in subjects analyzed from baseline to 6 weeks to 52 weeks are due to the fact that we did not use the 6 week time point in the final analysis based on the clinical decision that 6 weeks was too early in recovery to provide accurate information for clinical decision making. Therefore the patients used in the final analysis were those subjects who were able to and completed the assessment at pre-op and 1 year post-op which is how we get to the 20 subjects per group.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Clinical and Functional Outcomes Following Total Knee Replacement Using Two Different Implants
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Feb 26, 2016
Actual Study Completion Date :
Feb 26, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Stryker

Subjects will be receiving the Stryker Triathlon total knee replacement

Device: Stryker

Active Comparator: Zimmer

Subjects will be receiving a Zimmer NexGen total knee replacement

Device: Zimmer

Outcome Measures

Primary Outcome Measures

  1. Change in Lower Quarter Y-Balance Test (YBT-LQ) (Dynamic Balance) From Baseline to 6 Weeks Following Total Knee Replacement [Baseline (Pre-Operative) to 6 weeks following total knee replacement]

    The lower quarter y-balance test (YBT-LQ) is a test of dynamic balance in unilateral stance that has been deemed to be reliable and valid. The YBT-LQ consists of each patient standing on one leg and reaching as far as they can with their non-stance leg in the anterior, posteromedial and posterolateral direction while standing on the other foot on a centralized stance platform. The composite score is calculated as the sum of the three reach directions divided by 3 time the limb length and will be reported as a percentage of limb length.

  2. Change in Lower Quarter Y-Balance Test (YBT-LQ) (Dynamic Balance) From Baseline to 52 Weeks Following Total Knee Replacement [Baseline (Pre-Operative) to 52 weeks following total knee replacement]

    The lower quarter y-balance test (YBT-LQ) is a test of dynamic balance in unilateral stance that has been deemed to be reliable and valid. The YBT-LQ consists of each patient standing on one leg and reaching as far as they can with their non-stance leg in the anterior, posteromedial and posterolateral direction while standing on the other foot on a centralized stance platform. The composite score is calculated as the sum of the three reach directions divided by 3 time the limb length and will be reported as a percentage of limb length.

Secondary Outcome Measures

  1. Change in Walking Speed From Baseline to 52 Weeks Following Total Knee Replacement. [Baseline and 52 weeks following total knee replacement]

    Each subject will complete three walking trials at a self-selected comfortable walking speed along a 5 meter walkway in order to record walking speed at each time point.

  2. Walking Speed at 6 Weeks Following Total Knee Replacement. [6 weeks following total knee replacement]

    Each subject will complete three walking trials at a self-selected comfortable walking speed along a 5 meter walkway in order to record walking speed at each time point.

Other Outcome Measures

  1. Change in University of California, Los Angeles (UCLA) Activity Score From Baseline to 52 Weeks Following Total Knee Replacement. [Baseline and 52 weeks following total knee replacement]

    The UCLA activity score is a validated patient reported outcome of overall physical activity. Results on a scale of 1 to 10, 1 is "Wholly Inactive, dependent on others, and can not leave residence" and 10 is "Regularly participates in impact sports".

  2. University of California, Los Angeles (UCLA) Activity Score at 6 Weeks Following Total Knee Replacement. [6 weeks following total knee replacement]

    The UCLA activity score is a validated patient reported outcome of overall physical activity. Results on a scale of 1 to 10, 1 is "Wholly Inactive, dependent on others, and can not leave residence" and 10 is "Regularly participates in impact sports".

  3. Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) Total From Baseline to 52 Weeks Following Total Knee Replacement. [Baseline (Pre-Operative) and 52 weeks following total knee replacement]

    The KOOS is a standardized and validated patient outcome score that assesses functional limitation in patient with knee problems. KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.

  4. Change in Forgotten Joint Score (FJS) From 6 Weeks to 52 Weeks Following Total Knee Replacement. [6 weeks and 52 weeks following total knee replacement]

    The FJS is a patient reported measure of how bothersome the total joint replacement is for them, how much it affects daily activity and how much they are aware of the implant. The FJS is a 12-question survey regarding functional outcome, pain, stability, daily living, activity and sport. Scoring is from 0 to 4 with 0 as the best outcome; a low score means high satisfaction. Not all questions must be answered to score, all responses are summed and the total is divided by number of completed items multiplied by 25, with the final result subtracted from 100. The score range is from 0 to 100 with the highest score of 100 indicating the best outcome (the joint is completely "forgotten") and 0 indicating the worst outcome.

  5. Knee Society Score (KSS) [Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement]

    The KSS is a patient reported measure of knee function that is specific to patients who are scheduled to receive or have previously had a total knee replacement. This outcome measures both patient reported pain and function changes from prior to surgery through recovery. The score range is from 0 to 100. The highest score of 100 points will be obtained by a well-aligned knee with no pain, 125 degrees of motion, and negligible anteroposterior and mediolateral instability.

  6. Sit to Stand Time [Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement]

    The sit to stand test requires patients to stand up and sit down as many times as possible in 10 seconds from a standard arm chair.

  7. Timed Get up and go [Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement]

    The timed up and go requires a patient to rise from a chair walk three meters around a piece of tape and return to the chair again as quickly as possible.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients requiring primary total knee replacement

  2. Patients willing and able to comply with the follow-up visits and evaluations

  3. Patients willing to sign informed consent approved by the Institutional Review Board

Exclusion Criteria:
  1. Patients with inflammatory arthritis

  2. Patients with diabetic neuropathy

  3. Patients unable to ambulate without the use of an assistive device prior to surgery

  4. Patients unable to stand in single limb stance on each foot prior to surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27710

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Samuel S Wellman, MD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT01811563
Other Study ID Numbers:
  • Pro00043737
  • 193447
First Posted:
Mar 14, 2013
Last Update Posted:
Jun 2, 2017
Last Verified:
Apr 1, 2017

Study Results

Participant Flow

Recruitment Details 60 patients signed consent form but 12 were withdrawn at the time of surgery because they required a different implant not included in the study.
Pre-assignment Detail
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Period Title: Overall Study
STARTED 25 23
COMPLETED 20 20
NOT COMPLETED 5 3

Baseline Characteristics

Arm/Group Title Stryker Zimmer Total
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer Total of all reporting groups
Overall Participants 25 23 48
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
61.9
(8.0)
63.1
(7.3)
62.5
(7.6)
Sex: Female, Male (Count of Participants)
Female
14
56%
10
43.5%
24
50%
Male
11
44%
13
56.5%
24
50%
Region of Enrollment (participants) [Number]
United States
25
100%
23
100%
48
100%

Outcome Measures

1. Primary Outcome
Title Change in Lower Quarter Y-Balance Test (YBT-LQ) (Dynamic Balance) From Baseline to 6 Weeks Following Total Knee Replacement
Description The lower quarter y-balance test (YBT-LQ) is a test of dynamic balance in unilateral stance that has been deemed to be reliable and valid. The YBT-LQ consists of each patient standing on one leg and reaching as far as they can with their non-stance leg in the anterior, posteromedial and posterolateral direction while standing on the other foot on a centralized stance platform. The composite score is calculated as the sum of the three reach directions divided by 3 time the limb length and will be reported as a percentage of limb length.
Time Frame Baseline (Pre-Operative) to 6 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Only subjects that were able to complete all of the YBT assessments at 6 weeks post total knee replacement were included in the analyses.
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 21 22
YBT-LQ Composite Pre-Operative
69.98
(8.18)
67.52
(12.22)
YBT-LQ Composite 6 weeks
73.25
(7.95)
73.32
(9.15)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for implant independent of time
Statistical Test of Hypothesis p-Value 0.661
Comments
Method ANOVA
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for time independent of implant
Statistical Test of Hypothesis p-Value <0.001
Comments
Method ANOVA
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Interaction between implant and time
Statistical Test of Hypothesis p-Value 0.270
Comments
Method ANOVA
Comments
2. Primary Outcome
Title Change in Lower Quarter Y-Balance Test (YBT-LQ) (Dynamic Balance) From Baseline to 52 Weeks Following Total Knee Replacement
Description The lower quarter y-balance test (YBT-LQ) is a test of dynamic balance in unilateral stance that has been deemed to be reliable and valid. The YBT-LQ consists of each patient standing on one leg and reaching as far as they can with their non-stance leg in the anterior, posteromedial and posterolateral direction while standing on the other foot on a centralized stance platform. The composite score is calculated as the sum of the three reach directions divided by 3 time the limb length and will be reported as a percentage of limb length.
Time Frame Baseline (Pre-Operative) to 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Subjects used in the final analysis were those subjects who completed the assessment at pre-op and 1 year post-op (20 subjects per arm).
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 20 20
YBT-LQ Composite Pre-Operative
79.45
(10.46)
79.24
(7.89)
YBT-LQ Composite Post-Op 52 Weeks
70.44
(9.31)
69.42
(13.39)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for implant independent of time
Statistical Test of Hypothesis p-Value 0.856
Comments
Method ANOVA
Comments Main effect for implant, LQ-YBT Baseline to 52 weeks
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Time independent of implant, Baseline to 52 Weeks
Statistical Test of Hypothesis p-Value <0.001
Comments
Method ANOVA
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Implant by Time interaction, Baseline to 52 Weeks between Zimmer and Stryker
Statistical Test of Hypothesis p-Value 0.822
Comments
Method ANOVA
Comments
3. Secondary Outcome
Title Change in Walking Speed From Baseline to 52 Weeks Following Total Knee Replacement.
Description Each subject will complete three walking trials at a self-selected comfortable walking speed along a 5 meter walkway in order to record walking speed at each time point.
Time Frame Baseline and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 20 20
Walking Speed Pre-Operative
1.22
(0.21)
1.16
(0.28)
Walking Speed Post-Op 52 Weeks
1.41
(0.23)
1.28
(0.23)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for implant, Baseline to 52 weeks
Statistical Test of Hypothesis p-Value .158
Comments
Method ANOVA
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for time, Baseline to 52 weeks
Statistical Test of Hypothesis p-Value <0.001
Comments
Method ANOVA
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Interaction of time by implant, Baseline to 52 weeks
Statistical Test of Hypothesis p-Value 0.365
Comments
Method ANOVA
Comments
4. Secondary Outcome
Title Walking Speed at 6 Weeks Following Total Knee Replacement.
Description Each subject will complete three walking trials at a self-selected comfortable walking speed along a 5 meter walkway in order to record walking speed at each time point.
Time Frame 6 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 25 23
Mean (Standard Deviation) [miles per hour]
1.21
(0.28)
1.19
(0.22)
5. Other Pre-specified Outcome
Title Change in University of California, Los Angeles (UCLA) Activity Score From Baseline to 52 Weeks Following Total Knee Replacement.
Description The UCLA activity score is a validated patient reported outcome of overall physical activity. Results on a scale of 1 to 10, 1 is "Wholly Inactive, dependent on others, and can not leave residence" and 10 is "Regularly participates in impact sports".
Time Frame Baseline and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Subjects used in the final analysis were those subjects who completed the assessment at pre-op and 1 year post-op (20 subjects per arm).
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 20 20
UCLA Activity Pre-Operative
4.19
(1.33)
3.83
(1.38)
UCLA Activity Post-Op 52 Weeks
5.90
(1.55)
5.61
(1.91)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for implant, baseline to 52 weeks
Statistical Test of Hypothesis p-Value .416
Comments
Method ANOVA
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect for time, Baseline to 52 weeks
Statistical Test of Hypothesis p-Value <0.001
Comments
Method ANOVA
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Implant by time interaction, baseline to 52 weeks
Statistical Test of Hypothesis p-Value 0.917
Comments
Method ANOVA
Comments
6. Other Pre-specified Outcome
Title University of California, Los Angeles (UCLA) Activity Score at 6 Weeks Following Total Knee Replacement.
Description The UCLA activity score is a validated patient reported outcome of overall physical activity. Results on a scale of 1 to 10, 1 is "Wholly Inactive, dependent on others, and can not leave residence" and 10 is "Regularly participates in impact sports".
Time Frame 6 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Only subjects who were able to complete the UCLA at six weeks were included in the analysis.
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 25 22
Mean (Standard Deviation) [units on a scale]
4.48
(1.42)
4.73
(1.52)
7. Other Pre-specified Outcome
Title Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) Total From Baseline to 52 Weeks Following Total Knee Replacement.
Description The KOOS is a standardized and validated patient outcome score that assesses functional limitation in patient with knee problems. KOOS consists of 5 subscales; Pain, other Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). The previous week is the time period considered when answering the questions. Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
Time Frame Baseline (Pre-Operative) and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Subjects used in the final analysis were those subjects who completed the assessment at pre-op and 1 year post-op (20 subjects per arm).
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 20 20
KOOS Total, Baseline Pre-Operative
45.60
(12.32)
46.08
(13.50)
KOOS Total, Post-Op 52 week
67.32
(35.62)
64.24
(38.79)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect by implant, Baseline to 52 weeks
Statistical Test of Hypothesis p-Value 0.830
Comments
Method ANOVA
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Main effect by time, baseline to 52 weeks
Statistical Test of Hypothesis p-Value <0.001
Comments
Method ANOVA
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Interaction between implant and time, baseline to 52 weeks
Statistical Test of Hypothesis p-Value 0.728
Comments
Method ANOVA
Comments
8. Other Pre-specified Outcome
Title Change in Forgotten Joint Score (FJS) From 6 Weeks to 52 Weeks Following Total Knee Replacement.
Description The FJS is a patient reported measure of how bothersome the total joint replacement is for them, how much it affects daily activity and how much they are aware of the implant. The FJS is a 12-question survey regarding functional outcome, pain, stability, daily living, activity and sport. Scoring is from 0 to 4 with 0 as the best outcome; a low score means high satisfaction. Not all questions must be answered to score, all responses are summed and the total is divided by number of completed items multiplied by 25, with the final result subtracted from 100. The score range is from 0 to 100 with the highest score of 100 indicating the best outcome (the joint is completely "forgotten") and 0 indicating the worst outcome.
Time Frame 6 weeks and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Participants who completed the Forgotten Joint Score (FJS) at week 6 and week 52. Not all subjects completed the FJS.
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 20 20
FJS, at 6 weeks
69.63
(20.9)
76.59
(20.39)
FJS, at 52 weeks
37.7
(21.4)
30.8
(29.6)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Stryker, Zimmer
Comments
Type of Statistical Test Equivalence
Comments Between implants at 6 weeks
Statistical Test of Hypothesis p-Value 0.319
Comments
Method t-test, 2 sided
Comments
9. Other Pre-specified Outcome
Title Knee Society Score (KSS)
Description The KSS is a patient reported measure of knee function that is specific to patients who are scheduled to receive or have previously had a total knee replacement. This outcome measures both patient reported pain and function changes from prior to surgery through recovery. The score range is from 0 to 100. The highest score of 100 points will be obtained by a well-aligned knee with no pain, 125 degrees of motion, and negligible anteroposterior and mediolateral instability.
Time Frame Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
Only 20 subjects in each arm completed the assessment at 1 year post-op.
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 25 23
KSS Satisfaction, Baseline Pre-Operatively
11.1
(5.2)
13.6
(8.8)
KSS Satsifaction, 6 weeks
28.9
(7.3)
29.5
(8.8)
KSS Functional Activity, Baseline
44.3
(11.2)
47.0
(13.7)
KSS Functional Activity, 6 weeks
60.8
(18.1)
61.6
(16.7)
KSS Functional Activity, 52 weeks Post-operative
67.3
(35.6)
64.2
(38.8)
10. Other Pre-specified Outcome
Title Sit to Stand Time
Description The sit to stand test requires patients to stand up and sit down as many times as possible in 10 seconds from a standard arm chair.
Time Frame Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
The 6 week time point was not used in the final analysis based on the clinical decision that 6 weeks was too early in recovery to provide accurate information for clinical decision making. Subjects used in the final analysis were those subjects who completed the assessment at pre-op and 1 year post-op (20 subjects per arm).
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 25 23
Sit to stand Pre-Operative
3.90
(0.95)
4.34
(1.34)
Sit to stand Post-Op 6 weeks
4.5
(1.7)
4.6
(1.1)
Sit to stand Post-Op 52 weeks
5.40
(1.45)
5.47
(1.81)
11. Other Pre-specified Outcome
Title Timed Get up and go
Description The timed up and go requires a patient to rise from a chair walk three meters around a piece of tape and return to the chair again as quickly as possible.
Time Frame Baseline (Pre-Operative), 6 weeks and 52 weeks following total knee replacement

Outcome Measure Data

Analysis Population Description
The 6 week time point was not used in the final analysis based on the clinical decision that 6 weeks was too early in recovery to provide accurate information for clinical decision making. Subjects used in the final analysis were those subjects who completed the assessment at pre-op and 1 year post-op (20 subjects per arm).
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
Measure Participants 24 23
Timed up and go Pre-Operative
9.55
(3.86)
9.07
(2.48)
Timed up and go Post-Op 6 weeks
9.38
(3.58)
8.89
(1.89)
Timed up and go Post-Op 52 weeks
6.99
(1.8)
7.17
(1.39)

Adverse Events

Time Frame 52 weeks
Adverse Event Reporting Description
Arm/Group Title Stryker Zimmer
Arm/Group Description Subjects will be receiving the Stryker Triathlon total knee replacement Stryker Subjects will be receiving a Zimmer NexGen total knee replacement Zimmer
All Cause Mortality
Stryker Zimmer
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/25 (0%) 0/23 (0%)
Serious Adverse Events
Stryker Zimmer
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/25 (0%) 0/23 (0%)
Other (Not Including Serious) Adverse Events
Stryker Zimmer
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 1/25 (4%) 0/23 (0%)
Musculoskeletal and connective tissue disorders
Patient fell while completeing the 6 weeks testing 1/25 (4%) 1 0/23 (0%) 0

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Samuel Wellman, MD
Organization Duke University Medical Center
Phone 919-681-4055
Email samuel.wellman@duke.edu
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT01811563
Other Study ID Numbers:
  • Pro00043737
  • 193447
First Posted:
Mar 14, 2013
Last Update Posted:
Jun 2, 2017
Last Verified:
Apr 1, 2017